March 8th is International Women’s day, a global day of celebration of the social, political cultural and economic achievements of women. It is also a day for promoting the goal of greater gender parity across all sections of society. At Cromos Pharma, we are using this day to celebrate just a few of the many trailblazing women in healthcare.
The technological basis for both Pfizer/BioNTech and Moderna’s vaccines is mRNA. The core work behind the mRNA approach was carried out by Katalin Karikó, Hungarian- born scientist who after working in the US ended up working with BioNTech in Germany. In addition to fighting COVID-19, there is growing evidence that the mRNA vaccine platform could be used to fight other viruses, and other mRNA products may have additional uses, such as helping to treat skin disorders. The development of the Oxford/Astrazeneca vaccine was led by a woman, Professor Sarah Gilbert who in 2014 also led the first trial of an Ebola vaccine. The development of the Novavax vaccine candidate, which is at an advanced stage although as yet not approved, is being led by Nita Patel with an all-female team.
In 2020, Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in Chemistry for discovering one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. This technology has revolutionized the molecular life sciences, it is contributing to innovative cancer therapies and it is hoped it may be used to help find cures for devastating inherited diseases like Huntington’s disease. Just two years earlier in 2018, Frances Arnold was awarded the prize, along with Sir Gregory Winter and George Smith for their production of new enzymes and antibodies by directed evolution.
Women are also blazing a trail in pharma and biotech industries. Recent years have witnessed the emergence of several female leaders in leading companies. Emma Walmsley became CEO of GlaxoSmithKline in April of 2017, making her the first woman to run a major pharmaceutical company. Angela Hwang is the Group President of the Pfizer Biopharmaceuticals Group, which comprises 80% of Pfizer’s revenues, and is a member of the company’s Executive Leadership Team. In 2020, Reshma Kewalramani became the first female chief executive of a major biotech company when she was made CEO at Vertex Pharmaceuticals.
Here at Cromos Pharma, we are very proud that 66% of our team is female and that 62% of our clinical operation staff are women. In addition, 65% of our female team members occupy leadership positions including our COO, Stephanie Finnegan. We recognize and celebrate the tremendous contribution of women not only to our own company but to the wider clinical research sector. We are committed to creating a working environment that promotes equality of opportunity and career development through training and education programs.
We wish all our female team members a very Happy #IWD2021 and salute all women at the forefront of healthcare and research!
Cromos Pharma is pleased to share news about our latest project - an international double-blind placebo-controlled clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction (STEMI). The trial involving patients in the US and in Russia will investigate how a biologic RPH-104 developed by R-Pharm can reduce an acute inflammatory response after myocardial infarction and lead to improved outcomes for STEMI patients.
Throughout March we have been highlighting colorectal cancer, the amazing teams of researchers who are continuously fighting this disease, as well as the millions of patients and families who have been deeply affected by this silent killer. To close out this month of awareness-raising we want to introduce you to a real-life hero and colon cancer survivor - Arlene.
March is Colorectal Cancer Awareness Month. Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide according to 2020 figures from the Global Cancer Observatory.
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.